A group of physicians, scientists, and frontline professionals will hold a global COVID-19 summit in Nashville this Saturday. The Global Covid Summit will discuss insights and analyze findings regarding COVID-19 treatment and care. The group will place particular emphasis on questions around COVID-19 vaccinations for children.
The EU Strategy on COVID-19 Therapeutics delivers today its first outcome, with the announcement of the first portfolio of five therapeutics that could soon be available to treat patients across the EU.
In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support.
The two centers in Mozambique with which ISGlobal is working for the large ANTICOV clinical trial have begun recruiting participants following in the footsteps of the Democratic Republic of Congo (DRC), Ghana, Guinea, Kenya and Mali. The goal of the trial, which is being conducted in 13 African countries, is to find an effective treatment that prevents worsening in patients with mild to moderate COVID-19 symptoms.
INDIANAPOLIS — The U.S. Food and Drug Administration (FDA) has broadened the Emergency Use Authorization for Eli Lilly’s anti-inflammatory drug baricitinib used to treat COVID-19.FDA action provides physicians additional treatment regimen options for baricitinib to continue to meet the urgent medical needs posed by this pandemic.